• 1. The effect of oxidative stress upon intestinal sugar transport: an in vitro study using human intestinal epithelial (Caco-2) cells
  Nelson Andrade,Cláudia Silva,Fátima Martel Toxicol. Res. 2018 7 1236
• 2. Recent progress in the use of diaziridine-based sweetener derivatives to elucidate the chemoreception mechanism of the sweet taste receptor
  Makoto Hashimoto,Tomoya Nakagita,Takumi Misaka RSC Adv. 2021 11 32236
• 3. Rebaudioside A from Stevia rebaudiana stimulates GLP-1 release by enteroendocrine cells via bitter taste signalling pathways
  Francisca Noya-Leal,Nikkie van der Wielen,Maik Behrens,Sven Rouschop,Jeroen van Arkel,Maarten Jongsma,Renger Witkamp,Jurriaan J. Mes,Shanna Bastiaan-Net,Jocelijn Meijerink Food Funct. 2023 14 6914
• 4. Branched chain amino acids stimulate gut satiety hormone cholecystokinin secretion through activation of the umami taste receptor T1R1/T1R3 using an in vitro porcine jejunum model
  Min Tian,Jinghui Heng,Hanqing Song,Yufeng Zhang,Fang Chen,Wutai Guan,Shihai Zhang Food Funct. 2019 10 3356
• 5. Natural product modulators of human sensations and mood: molecular mechanisms and therapeutic potential
  Tomá? Pluskal,Jing-Ke Weng Chem. Soc. Rev. 2018 47 1592

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives 2-phenoxypropionic acids Alkyloxyphenoxypropionic acids

Introduction to 2-(4-Methoxyphenoxy)propanoic acid (CAS No. 13794-15-5)

2-(4-Methoxyphenoxy)propanoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 13794-15-5, is a compound of significant interest in the field of pharmaceutical chemistry and bioorganic synthesis. This molecule, featuring a propionic acid moiety linked to a phenoxy group substituted with a methoxy group at the para position, exhibits structural features that make it a valuable intermediate in the development of various bioactive molecules. The unique arrangement of functional groups in this compound imparts distinct chemical properties, making it a versatile building block for medicinal chemists.

The structural framework of 2-(4-Methoxyphenoxy)propanoic acid consists of a linear aliphatic chain terminated by a carboxylic acid group, connected to an aromatic ring system. The presence of the methoxy group on the aromatic ring enhances its solubility in polar solvents and influences its electronic properties, thereby affecting its reactivity and interaction with biological targets. This compound’s chemical profile has positioned it as a candidate for further derivatization, enabling the synthesis of more complex molecules with potential therapeutic applications.

In recent years, there has been growing interest in exploring the pharmacological potential of 2-(4-Methoxyphenoxy)propanoic acid and its derivatives. Research has highlighted its utility as a precursor in the synthesis of molecules targeting neurological disorders, inflammatory pathways, and metabolic diseases. The phenoxypropionic acid scaffold is particularly noteworthy for its ability to modulate enzyme activity and receptor binding, making it a promising candidate for drug discovery initiatives.

One of the most compelling aspects of 2-(4-Methoxyphenoxy)propanoic acid is its role in the development of novel therapeutic agents. Studies have demonstrated its efficacy in preclinical models as an inhibitor of specific kinases and enzymes involved in disease progression. For instance, derivatives of this compound have shown promise in mitigating oxidative stress and inflammation, key pathological mechanisms underlying conditions such as neurodegenerative diseases and chronic inflammation. The methoxy substitution at the aromatic ring further enhances its bioavailability and metabolic stability, contributing to its suitability for clinical development.

The synthetic pathways involving 2-(4-Methoxyphenoxy)propanoic acid are also noteworthy from an industrial perspective. Its synthesis typically involves phenol methylation followed by propylation and carboxylation steps, showcasing an elegant interplay of organic transformations. Advances in green chemistry have led to more sustainable methods for producing this compound, emphasizing the importance of environmentally conscious synthetic strategies in pharmaceutical manufacturing.

The pharmacokinetic profile of 2-(4-Methoxyphenoxy)propanoic acid is another area of active investigation. Researchers are leveraging computational modeling and high-throughput screening techniques to optimize its absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties. These efforts aim to enhance drug-like characteristics and improve overall therapeutic efficacy while minimizing adverse effects.

Recent publications have explored the potential applications of 2-(4-Methoxyphenoxy)propanoic acid in oncology research. Its derivatives have been investigated for their ability to disrupt cancer cell signaling pathways, particularly those involving aberrant tyrosine kinases. The phenoxypropionic acid core is well-suited for designing molecules that can selectively inhibit growth factor receptors overexpressed in tumor cells, offering a targeted approach to cancer therapy.

The role of 2-(4-Methoxyphenoxy)propanoic acid in drug discovery extends beyond oncology. It has been utilized in the development of agents targeting central nervous system (CNS) disorders such as Alzheimer’s disease and Parkinson’s disease. The compound’s ability to cross the blood-brain barrier and interact with neuronal receptors makes it a valuable scaffold for designing neuroprotective agents. Furthermore, its derivatives have shown promise in preclinical studies as potential treatments for depression and anxiety disorders.

The versatility of 2-(4-Methoxyphenoxy)propanoic acid is further underscored by its application in anti-inflammatory research. Inflammatory processes are central to numerous chronic diseases, including rheumatoid arthritis and cardiovascular disorders. By modulating key inflammatory mediators such as prostaglandins and leukotrienes, derivatives of this compound have demonstrated anti-inflammatory effects comparable to existing therapeutics while exhibiting improved tolerability profiles.

Future directions in the study of 2-(4-Methoxyphenoxy)propanoic acid include exploring its role in metabolic diseases such as diabetes and obesity. Preliminary data suggest that certain derivatives can enhance insulin sensitivity and promote glucose uptake in target tissues. These findings open new avenues for developing treatments that address metabolic dysregulation at multiple levels.

The industrial significance of 2-(4-Methoxyphenoxy)propanoic acid cannot be overstated. Its widespread use as an intermediate underscores its importance in pharmaceutical manufacturing processes worldwide. As demand for high-quality active pharmaceutical ingredients (APIs) grows, efficient synthetic routes will be essential to meet market needs while adhering to stringent regulatory standards.

In conclusion,2-(4-Methoxyphenoxy)propanoic acid (CAS No. 13794-15-5) represents a cornerstone molecule in modern drug discovery efforts. Its unique structural features provide a foundation for designing novel therapeutic agents targeting diverse diseases with high precision and efficacy. Continued research into this compound promises further insights into its pharmacological potential while driving innovation across multiple sectors within the pharmaceutical industry.

• 51338-26-2(Propanoic acid,2-(4-phenoxyphenoxy)-)
• 1912-23-8(Propanoic acid,2-phenoxy-, (2S)-)
• 17274-05-4(Propanoic acid,2-phenoxy-, sodium salt (1:1))
• 652149-65-0(Propanoic acid, 2,2'-[1,3-phenylenebis(oxy)]bis-, (2S,2'S)- (9CI))
• 1129-46-0((R)-2-Phenoxypropionic Acid)
• 940-31-8(2-phenoxypropanoic acid)
• 150767-88-7(Propanoic acid,2-(4-methoxyphenoxy)-, sodium salt (1:1))
• 150436-68-3(Lactisole)
• 652149-64-9(Propanoic acid, 2,2'-[1,4-phenylenebis(oxy)]bis-, (2S,2'S)- (9CI))
• 94050-90-5((R)-(+)-2-(4-Hydroxyphenoxy)propionic Acid)